{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:57Z","timestamp":1792798677026,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI157764"],"award-info":[{"award-number":["R01AI157764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53209-9","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:35:47Z","timestamp":1780436147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BST-2 inhibits SARS-CoV-2 egress at intracellular membranes and is neutralized by ORF7a"],"prefix":"10.1038","volume":"16","author":[{"given":"Adam","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"53209_CR1","doi-asserted-by":"publisher","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","volume":"2","author":"MH Malim","year":"2012","unstructured":"Malim, M. H. & Bieniasz, P. D. HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect. Med. 2 (5), a006940 (2012).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"43","key":"53209_CR2","doi-asserted-by":"publisher","first-page":"18428","DOI":"10.1073\/pnas.1011485107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang, H. et al. Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc. Natl. Acad. Sci. U S A. 107 (43), 18428\u201318432 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"53209_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","volume":"139","author":"D Perez-Caballero","year":"2009","unstructured":"Perez-Caballero, D. et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139 (3), 499\u2013511 (2009).","journal-title":"Cell"},{"issue":"4","key":"53209_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2174\/157016212800792522","volume":"10","author":"H Fujita","year":"2012","unstructured":"Fujita, H. et al. Intracellular logistics of BST-2\/tetherin. Curr. HIV Res. 10 (4), 321\u2013326 (2012).","journal-title":"Curr. HIV Res."},{"issue":"4","key":"53209_CR5","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1128\/JVI.02211-08","volume":"83","author":"N Jouvenet","year":"2009","unstructured":"Jouvenet, N. et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83 (4), 1837\u20131844 (2009).","journal-title":"J. Virol."},{"issue":"8","key":"53209_CR6","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.0811014106","volume":"106","author":"RL Kaletsky","year":"2009","unstructured":"Kaletsky, R. L. et al. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U S A. 106 (8), 2886\u20132891 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"20","key":"53209_CR7","doi-asserted-by":"publisher","first-page":"10569","DOI":"10.1128\/JVI.00103-10","volume":"84","author":"SR Radoshitzky","year":"2010","unstructured":"Radoshitzky, S. R. et al. Infectious Lassa virus, but not filoviruses, is restricted by BST-2\/tetherin. J. Virol. 84 (20), 10569\u201310580 (2010).","journal-title":"J. Virol."},{"issue":"12","key":"53209_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1089\/aid.2009.0253","volume":"25","author":"A Tokarev","year":"2009","unstructured":"Tokarev, A. et al. Antiviral activity of the interferon-induced cellular protein BST-2\/tetherin. AIDS Res. Hum. Retroviruses. 25 (12), 1197\u20131210 (2009).","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"5","key":"53209_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1042\/BCJ20160861","volume":"474","author":"S Hu","year":"2017","unstructured":"Hu, S. et al. BST-2 restricts IAV release and is countered by the viral M2 protein. Biochem. J. 474 (5), 715\u2013730 (2017).","journal-title":"Biochem. J."},{"issue":"23","key":"53209_CR10","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.1128\/JVI.02274-15","volume":"89","author":"JK Taylor","year":"2015","unstructured":"Taylor, J. K. et al. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. J. Virol. 89 (23), 11820\u201311833 (2015).","journal-title":"J. Virol."},{"key":"53209_CR11","doi-asserted-by":"crossref","unstructured":"Hagelauer, E. et al. Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists. Viruses, 15(12). (2023).","DOI":"10.3390\/v15122364"},{"issue":"12","key":"53209_CR12","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.molcel.2021.04.008","volume":"81","author":"L Martin-Sancho","year":"2021","unstructured":"Martin-Sancho, L. et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol. Cell. 81 (12), 2656\u20132668e8 (2021).","journal-title":"Mol. Cell."},{"key":"53209_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.virol.2013.11.030","volume":"449","author":"SM Wang","year":"2014","unstructured":"Wang, S. M., Huang, K. J. & Wang, C. T. BST2\/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface. Virology 449, 287\u2013296 (2014).","journal-title":"Virology"},{"issue":"10","key":"53209_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1080\/15548627.2019.1707487","volume":"16","author":"N Kong","year":"2020","unstructured":"Kong, N. et al. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy. Autophagy 16 (10), 1737\u20131752 (2020).","journal-title":"Autophagy"},{"key":"53209_CR15","doi-asserted-by":"publisher","first-page":"110607","DOI":"10.1016\/j.virol.2025.110607","volume":"610","author":"SA Mothae","year":"2025","unstructured":"Mothae, S. A., Chiliza, T. E. & Mvubu, N. E. SARS-CoV-2 host-pathogen interactome: insights into more players during pathogenesis. Virology 610, 110607 (2025).","journal-title":"Virology"},{"key":"53209_CR16","doi-asserted-by":"crossref","unstructured":"Katiyar, H. et al. SARS-CoV-2 Assembly: Gaining Infectivity and Beyond. Viruses, 16(11). (2024).","DOI":"10.3390\/v16111648"},{"issue":"9","key":"53209_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.tcb.2023.12.006","volume":"34","author":"MC Sergio","year":"2024","unstructured":"Sergio, M. C. et al. Membrane remodeling and trafficking piloted by SARS-CoV-2. Trends Cell. Biol. 34 (9), 785\u2013800 (2024).","journal-title":"Trends Cell. Biol."},{"issue":"6","key":"53209_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/mmi.14907","volume":"117","author":"K Prydz","year":"2022","unstructured":"Prydz, K. & Saraste, J. The life cycle and enigmatic egress of coronaviruses. Mol. Microbiol. 117 (6), 1308\u20131316 (2022).","journal-title":"Mol. Microbiol."},{"issue":"5","key":"53209_CR19","doi-asserted-by":"publisher","first-page":"e0237121","DOI":"10.1128\/mBio.02371-21","volume":"12","author":"D Bracquemond","year":"2021","unstructured":"Bracquemond, D. & Muriaux, D. Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress. mBio 12 (5), e0237121 (2021).","journal-title":"mBio"},{"key":"53209_CR20","doi-asserted-by":"crossref","unstructured":"Sicari, D. et al. Role of the early secretory pathway in SARS-CoV-2 infection. J. Cell. Biol., 219(9). (2020).","DOI":"10.1083\/jcb.202006005"},{"issue":"1","key":"53209_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2011","unstructured":"Neuman, B. W. et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 174 (1), 11\u201322 (2011).","journal-title":"J. Struct. Biol."},{"issue":"9","key":"53209_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/fvl-2020-0124","volume":"15","author":"SM Haque","year":"2020","unstructured":"Haque, S. M. et al. A comprehensive review about SARS-CoV-2. Future Virol. 15 (9), 625\u2013648 (2020).","journal-title":"Future Virol."},{"issue":"6","key":"53209_CR23","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.cell.2020.10.039","volume":"183","author":"S Ghosh","year":"2020","unstructured":"Ghosh, S. et al. \u03b2-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell 183 (6), 1520\u20131535e14 (2020).","journal-title":"Cell"},{"issue":"4","key":"53209_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.devcel.2020.12.010","volume":"56","author":"G Miao","year":"2021","unstructured":"Miao, G. et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev. Cell. 56 (4), 427\u2013442e5 (2021).","journal-title":"Dev. Cell."},{"issue":"51","key":"53209_CR25","doi-asserted-by":"publisher","first-page":"eade5085","DOI":"10.1126\/sciadv.ade5085","volume":"8","author":"C Guo","year":"2022","unstructured":"Guo, C. et al. The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation. Sci. Adv. 8 (51), eade5085 (2022).","journal-title":"Sci. Adv."},{"issue":"1","key":"53209_CR26","doi-asserted-by":"publisher","first-page":"eabl4895","DOI":"10.1126\/sciadv.abl4895","volume":"8","author":"KM Scherer","year":"2022","unstructured":"Scherer, K. M. et al. SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi\/ERGIC and lysosome-mediated egress. Sci. Adv. 8 (1), eabl4895 (2022).","journal-title":"Sci. Adv."},{"issue":"6","key":"53209_CR27","doi-asserted-by":"publisher","first-page":"e1013295","DOI":"10.1371\/journal.ppat.1013295","volume":"21","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion. PLoS Pathog. 21 (6), e1013295 (2025).","journal-title":"PLoS Pathog."},{"issue":"6","key":"53209_CR28","doi-asserted-by":"publisher","first-page":"e3002738","DOI":"10.1371\/journal.pbio.3002738","volume":"23","author":"X Yin","year":"2025","unstructured":"Yin, X. et al. Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. PLoS Biol. 23 (6), e3002738 (2025).","journal-title":"PLoS Biol."},{"issue":"9","key":"53209_CR29","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1242\/jcs.195412","volume":"130","author":"N Roy","year":"2017","unstructured":"Roy, N. et al. Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2. J. Cell. Sci. 130 (9), 1596\u20131611 (2017).","journal-title":"J. Cell. Sci."},{"issue":"5","key":"53209_CR30","doi-asserted-by":"publisher","first-page":"e1000450","DOI":"10.1371\/journal.ppat.1000450","volume":"5","author":"RS Mitchell","year":"2009","unstructured":"Mitchell, R. S. et al. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5 (5), e1000450 (2009).","journal-title":"PLoS Pathog"},{"issue":"12","key":"53209_CR31","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/j.1600-0854.2011.01277.x","volume":"12","author":"M Dub\u00e9","year":"2011","unstructured":"Dub\u00e9, M. et al. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic 12 (12), 1714\u20131729 (2011).","journal-title":"Traffic"},{"issue":"4","key":"53209_CR32","doi-asserted-by":"publisher","first-page":"e1003299","DOI":"10.1371\/journal.ppat.1003299","volume":"9","author":"MW McNatt","year":"2013","unstructured":"McNatt, M. W., Zang, T. & Bieniasz, P. D. Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog. 9 (4), e1003299 (2013).","journal-title":"PLoS Pathog"},{"issue":"14","key":"53209_CR33","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1128\/JVI.02636-09","volume":"84","author":"LA Lopez","year":"2010","unstructured":"Lopez, L. A. et al. Ebola virus glycoprotein counteracts BST-2\/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J. Virol. 84 (14), 7243\u20137255 (2010).","journal-title":"J. Virol."},{"issue":"4","key":"53209_CR34","doi-asserted-by":"publisher","first-page":"e1000843","DOI":"10.1371\/journal.ppat.1000843","volume":"6","author":"C Pardieu","year":"2010","unstructured":"Pardieu, C. et al. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6 (4), e1000843 (2010).","journal-title":"PLoS Pathog"},{"issue":"1","key":"53209_CR35","doi-asserted-by":"publisher","first-page":"e1011912","DOI":"10.1371\/journal.ppat.1011912","volume":"20","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2\/Tetherin. PLoS Pathog. 20 (1), e1011912 (2024).","journal-title":"PLoS Pathog"},{"issue":"2","key":"53209_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/15548627.2022.2084686","volume":"19","author":"P Hou","year":"2023","unstructured":"Hou, P. et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy 19 (2), 551\u2013569 (2023).","journal-title":"Autophagy"},{"issue":"12","key":"53209_CR37","doi-asserted-by":"publisher","first-page":"e57224","DOI":"10.15252\/embr.202357224","volume":"24","author":"H Stewart","year":"2023","unstructured":"Stewart, H. et al. Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release. EMBO Rep. 24 (12), e57224 (2023).","journal-title":"EMBO Rep."},{"issue":"22","key":"53209_CR38","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1128\/JVI.01052-08","volume":"82","author":"YL Siu","year":"2008","unstructured":"Siu, Y. L. et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 82 (22), 11318\u201311330 (2008).","journal-title":"J. Virol."},{"issue":"4","key":"53209_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/cells10040853","volume":"10","author":"B Kumar","year":"2021","unstructured":"Kumar, B. et al. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles. Cells 10 (4), 853 (2021).","journal-title":"Cells"},{"issue":"6575","key":"53209_CR40","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.abl6184","volume":"374","author":"AM Syed","year":"2021","unstructured":"Syed, A. M. et al. Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles. Science 374 (6575), 1626\u20131632 (2021).","journal-title":"Science"},{"issue":"4","key":"53209_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","volume":"3","author":"N Van Damme","year":"2008","unstructured":"Van Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell. Host Microbe. 3 (4), 245\u2013252 (2008).","journal-title":"Cell. Host Microbe"},{"issue":"2","key":"53209_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.virol.2006.11.027","volume":"361","author":"S Stertz","year":"2007","unstructured":"Stertz, S. et al. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361 (2), 304\u2013315 (2007).","journal-title":"Virology"},{"key":"53209_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","volume":"64","author":"CA de Haan","year":"2005","unstructured":"de Haan, C. A. & Rottier, P. J. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 64, 165\u2013230 (2005).","journal-title":"Adv. Virus Res."},{"issue":"1","key":"53209_CR44","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","volume":"11","author":"S Klein","year":"2020","unstructured":"Klein, S. et al. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat. Commun. 11 (1), 5885 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"53209_CR45","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1038\/s41467-022-32019-3","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat. Commun. 13 (1), 4399 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"53209_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","volume":"7","author":"W Yan","year":"2022","unstructured":"Yan, W. et al. Structural biology of SARS-CoV-2: open the door for novel therapies. Signal. Transduct. Target. Ther. 7 (1), 26 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"53209_CR47","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1080\/07391102.2021.2016490","volume":"41","author":"P Kumar","year":"2023","unstructured":"Kumar, P. et al. An insight into SARS-CoV-2 membrane protein interaction with spike, envelope, and nucleocapsid proteins. J. Biomol. Struct. Dyn. 41 (3), 1062\u20131071 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"53209_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev.genet.42.110807.091704","volume":"42","author":"D Wolf","year":"2008","unstructured":"Wolf, D. & Goff, S. P. Host restriction factors blocking retroviral replication. Annu. Rev. Genet. 42, 143\u2013163 (2008).","journal-title":"Annu. Rev. Genet."},{"issue":"9","key":"53209_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/jir.2009.0077","volume":"29","author":"S Neil","year":"2009","unstructured":"Neil, S. & Bieniasz, P. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29 (9), 569\u2013580 (2009).","journal-title":"J. Interferon Cytokine Res."},{"issue":"9","key":"53209_CR50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tim.2010.06.010","volume":"18","author":"DT Evans","year":"2010","unstructured":"Evans, D. T. et al. BST-2\/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18 (9), 388\u2013396 (2010).","journal-title":"Trends Microbiol."},{"issue":"10","key":"53209_CR51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1034\/j.1600-0854.2003.00129.x","volume":"4","author":"S Kupzig","year":"2003","unstructured":"Kupzig, S. et al. Bst-2\/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4 (10), 694\u2013709 (2003).","journal-title":"Traffic"},{"key":"53209_CR52","doi-asserted-by":"publisher","first-page":"110285","DOI":"10.1016\/j.virol.2024.110285","volume":"601","author":"R Sultana","year":"2025","unstructured":"Sultana, R. & Stahelin, R. V. Strengths and limitations of SARS-CoV-2 virus-like particle systems. Virology 601, 110285 (2025).","journal-title":"Virology"},{"key":"53209_CR53","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1038\/srep11736","volume":"5","author":"M Lv","year":"2015","unstructured":"Lv, M. et al. Identification of BST-2\/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Sci. Rep. 5, 11736 (2015).","journal-title":"Sci. Rep."},{"key":"53209_CR54","doi-asserted-by":"publisher","first-page":"e17180","DOI":"10.7554\/eLife.17180","volume":"5","author":"JR Edgar","year":"2016","unstructured":"Edgar, J. R. et al. Tetherin is an exosomal tether. eLife 5, e17180 (2016).","journal-title":"eLife"},{"key":"53209_CR55","doi-asserted-by":"crossref","unstructured":"Stewart, H., et al., Tetherin antagonism by SARS\u2010CoV\u20102 ORF3a and spike protein enhances virus release. EMBO reports, 2023. 24(12): p. e57224.","DOI":"10.15252\/embr.202357224"},{"key":"53209_CR56","doi-asserted-by":"crossref","unstructured":"Miller, A. N. et al. The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins. Elife, 12. (2023).","DOI":"10.7554\/eLife.84477"},{"key":"53209_CR57","doi-asserted-by":"crossref","unstructured":"Su, W. Q., Yu, X. J. & Zhou, C. M. SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response. Viruses, 13(12). (2021).","DOI":"10.3390\/v13122467"},{"issue":"23","key":"53209_CR58","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1016\/j.devcel.2021.10.006","volume":"56","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress. Dev. Cell. 56 (23), 3250\u20133263e5 (2021).","journal-title":"Dev. Cell."},{"key":"53209_CR59","doi-asserted-by":"crossref","unstructured":"Walia, K. et al. SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle. Nat Commun, 15(1): p. 2053. (2024).","DOI":"10.1038\/s41467-024-46417-2"},{"issue":"1","key":"53209_CR60","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1038\/s41467-025-59475-x","volume":"16","author":"S Hartmann","year":"2025","unstructured":"Hartmann, S. et al. SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity. Nat. Commun. 16 (1), 4393 (2025).","journal-title":"Nat. Commun."},{"issue":"11","key":"53209_CR61","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/open.202100217","volume":"10","author":"M Petrosino","year":"2021","unstructured":"Petrosino, M. et al. Zn-Induced Interactions Between SARS-CoV-2 orf7a and BST2\/Tetherin. ChemistryOpen 10 (11), 1133\u20131141 (2021).","journal-title":"ChemistryOpen"},{"issue":"6","key":"53209_CR62","doi-asserted-by":"publisher","first-page":"184174","DOI":"10.1016\/j.bbamem.2023.184174","volume":"1865","author":"MM Mann","year":"2023","unstructured":"Mann, M. M. et al. Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a. Biochimica et Biophysica Acta (BBA) -. Biomembranes 1865 (6), 184174 (2023).","journal-title":"Biomembranes"},{"issue":"3","key":"53209_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1140\/epjp\/s13360-023-03731-w","volume":"138","author":"S Botticelli","year":"2023","unstructured":"Botticelli, S. et al. The role of Zn ions in the interaction between SARS-CoV-2 orf7a protein and BST2\/tetherin. Eur. Phys. J. Plus. 138 (3), 216 (2023).","journal-title":"Eur. Phys. J. Plus"},{"issue":"7","key":"53209_CR64","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/boc.202000158","volume":"113","author":"S Miserey-Lenkei","year":"2021","unstructured":"Miserey-Lenkei, S. et al. A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types. Biol. Cell. 113 (7), 311\u2013328 (2021).","journal-title":"Biol. Cell."},{"issue":"3","key":"53209_CR65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy, L. et al. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell 183 (3), 739\u2013751e8 (2020).","journal-title":"Cell"},{"key":"53209_CR66","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition. Proc. Natl. Acad. Sci. U S A, 118(42). (2021).","DOI":"10.1073\/pnas.2113401118"},{"issue":"10","key":"53209_CR67","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1038\/s41596-020-0365-x","volume":"15","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Combined proximity labeling and affinity purification-mass spectrometry workflow for mapping and visualizing protein interaction networks. Nat. Protoc. 15 (10), 3182\u20133211 (2020).","journal-title":"Nat. Protoc."},{"issue":"7807","key":"53209_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581 (7807), 221\u2013224 (2020).","journal-title":"Nature"},{"issue":"1","key":"53209_CR69","doi-asserted-by":"publisher","first-page":"21877","DOI":"10.1038\/s41598-020-78656-w","volume":"10","author":"H Swann","year":"2020","unstructured":"Swann, H. et al. Minimal system for assembly of SARS-CoV-2 virus like particles. Sci. Rep. 10 (1), 21877 (2020).","journal-title":"Sci. Rep."},{"issue":"12","key":"53209_CR70","doi-asserted-by":"publisher","first-page":"e1002456","DOI":"10.1371\/journal.ppat.1002456","volume":"7","author":"M Lehmann","year":"2011","unstructured":"Lehmann, M. et al. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog. 7 (12), e1002456 (2011).","journal-title":"PLoS Pathog"},{"issue":"21","key":"53209_CR71","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1128\/JVI.78.21.11841-11852.2004","volume":"78","author":"K Luo","year":"2004","unstructured":"Luo, K. et al. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J. Virol. 78 (21), 11841\u201311852 (2004).","journal-title":"J. Virol."},{"issue":"32","key":"53209_CR72","doi-asserted-by":"publisher","first-page":"28498","DOI":"10.1074\/jbc.M111.239053","volume":"286","author":"J Cooper","year":"2011","unstructured":"Cooper, J. et al. Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J. Biol. Chem. 286 (32), 28498\u201328510 (2011).","journal-title":"J. Biol. Chem."},{"issue":"20","key":"53209_CR73","doi-asserted-by":"publisher","first-page":"11242","DOI":"10.1128\/JVI.00544-12","volume":"86","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Defective HIV-1 particle assembly in AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2. J. Virol. 86 (20), 11242\u201311253 (2012).","journal-title":"J. Virol."},{"issue":"8","key":"53209_CR74","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1074\/jbc.M115.708123","volume":"291","author":"D Dotson","year":"2016","unstructured":"Dotson, D. et al. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression. J. Biol. Chem. 291 (8), 4236\u20134246 (2016).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53209-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:01:31Z","timestamp":1786582891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53209-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53209"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53209-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25196"}}